Efficacy of Nebulised Hypertonic Saline (3%) Among Children With Bronchiolitis.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01276821|
Recruitment Status : Completed
First Posted : January 13, 2011
Results First Posted : May 31, 2013
Last Update Posted : May 31, 2013
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor); Primary Purpose: Treatment|
Drug: L-Epinephrine and Normal Saline (0.9%)
Drug: L-Epinephrine and Hypertonic Saline (3%)
Subjects were recruited from previously healthy children aged 6 weeks to 24 months with first episode of wheezing who visited the OPD and ER of Kanti Children Hospital and met the clinical definition of bronchiolitis.
Recruitment occurred on weekdays from 8:00 to 17:00 Hours. Out of 754 screened children, 159 were first episode wheezers.